Our biomarker PRO-C3 measured in serum allows us to quantify the formation of type III collagen in the liver and help predict outcomes in liver disease. In patients with hepatitis C, the levels of serum PRO-C3 are related to disease outcomes (Figure 2.) Patients with hepatitis C and higher serum levels of PRO-C3 are more likely to have a sooner outcome than patients with low PRO-C3.[2]
Figure 2. PRO-C3 is a predictor of clinical outcome[2]
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.
